Meitheal Pharmaceuticals, Inc.

From its vibrant culture to its role as a location for global healthcare conversations, Miami offers the perfect backdrop for this year’s Hospital Buyers Conference. We’re excited to join industry leaders in the heart of South Florida to explore innovative solutions for hospital pharmacy and purchasing. Our team will be on-site to share how Meitheal’s portfolio of sustainable medications is helping hospitals improve access, control costs, and support better outcomes for patients. If you’re attending, we’d love to meet you! Let’s talk about how we can partner to strengthen your supply chain and bring greater value to hospital pharmacy operations.

We’re proud to announce the appointment of Dr. Keith Robinson as Chief Medical Officer and Dr. Lonnie Brent as Senior Vice President of Medical Affairs. These key additions mark a significant step in Meitheal’s continued evolution into an innovation-driven biopharmaceutical organization. With decades of combined experience across clinical development, regulatory strategy, and medical affairs, Dr. Robinson and Dr. Brent will play critical roles in advancing our growing pipeline. Learn more about our leadership and pipeline at https://lnkd.in/g2rBNE4y 

We’re excited to share that Angie Brym, Adam Reno and Jacque Nowik will be representing Meitheal at the Evernorth Pharma Summit, taking place July 29–30 in Atlanta’s historic Centennial Park. This year’s theme, “Experience the Why,” is a powerful reminder of the people at the heart of everything we do — patients, families and providers. At Meitheal, we’re proud to support that mission by delivering sustainable solutions to generic medicines that expand access and support better outcomes. We look forward to two days of meaningful conversations and shared purpose with fellow industry leaders. See you in Atlanta!

We’re excited to connect virtually at the 2025 HCP Summer Hospital Pharmacy Conference, where pharmacy leaders and suppliers come together to explore new ways to improve access, efficiency, and outcomes across hospital systems. The Meitheal team will be participating in one-on-one meetings and interactive sessions to share how our portfolio of reliable, generic medications is supporting hospitals in delivering high-quality, cost-effective care. Think sustainability. Think Meitheal.

Meitheal is excited to be attending Premier’s Annual Breakthroughs Conference 2025 in National Harbor, MD, where healthcare leaders from across the country gather to explore new ways to drive innovation, improve outcomes, and expand access to care. The Meitheal team will be on-site and ready to connect—stop by booth #615 to meet us and learn how we’re delivering practical, reliable, and stable generic solutions that support affordability and long-term value across the healthcare system. We’re proud to be part of this important conversation and look forward to building stronger partnerships that move healthcare forward. See you at Breakthroughs 2025! Think sustainability. Think Meitheal. #Generics #Pharma #Healthcare

Xturnpoint offers various partnership models to help innovators reach their next preclinical milestone.   By leveraging an existing and trusted CRO partnership and our internal biosimilar expertise, we progressed an insulin aspart biosimilar to FDA submission in less than 1 year. Though the assay was complicated and the runway was rigid, we acted nimbly, achieving high sensitivity and specificity, and met our primary endpoints with high confidence.   Xturnpoint provides the capital, partnership, and industry vision to help early-stage innovators accelerate to critical early inflections in value with confidence. This insulin aspart biosimilar case with Inotiv and Meitheal Pharmaceuticals is just one example of how Xturnpoint offers the flexibility required to meet our partners’ needs comprehensively.

With its scenic Blue Ridge views and vibrant healthcare community, Asheville, NC is the perfect setting for NCAP 2025—where pharmacy professionals from across the state come together to shape the future of patient care. We’re proud to share that Dion Wolters will be representing Meitheal at this year’s event, connecting with North Carolina’s pharmacy leaders to discuss how practical, reliable and stable generic medications can improve access and support better outcomes. If you’re attending NCAP 2025, be sure to say hello to Dion and learn more about Meitheal’s commitment to advancing pharmacy practice and access to care. Think sustainability. Think Meitheal.